Papillary thyroid carcinomas with lung metastases
Limited information is available on the presentation, treatment outcomes, and prognostic factors of papillary thyroid carcinoma with lung metastases. This study retrospectively analyzed the data of 2003 patients with thyroid cancer who were treated and followed up at Chang Gung Memorial Hospital fro...
Saved in:
Published in | Thyroid (New York, N.Y.) Vol. 14; no. 12; p. 1091 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Limited information is available on the presentation, treatment outcomes, and prognostic factors of papillary thyroid carcinoma with lung metastases.
This study retrospectively analyzed the data of 2003 patients with thyroid cancer who were treated and followed up at Chang Gung Memorial Hospital from January 1979 to December 2002. In total, 1516 papillary thyroid carcinomas were enrolled. One hundred two (6.7%) papillary thyroid carcinomas with lung metastases were followed including 57 women with mean age of 41.7 +/- 17.3 years and 45 men with mean age of 49.6 +/- 17.2 years. These patients included 52 patients with papillary thyroid carcinoma who presented with lung metastases at the time of diagnosis. The 102 cases of papillary thyroid carcinomas with lung metastases included 72 cases with lung metastases only, and 30 cases with other organ involvement.
After mean follow-up periods of 8.8 +/- 0.6 years, 28 (27.5%) of the patients with lung metastasis died, while 6 improved to clinical stage I. The 5-, 10-, 15-, and 20-year survival rates in patients with papillary thyroid carcinoma without distant metastasis and in the lung metastases groups were 99.0%, 98.5%, 98.0%, 98.0%, and 91.3%, 75.0%, 64.0%, 51.2%, respectively. Comparing the Kaplan-Meier survival curves between the patients with papillary thyroid carcinomas with lung metastases only and those with multiorgan metastases demonstrates no statistically significant difference in mortality rates. However, age, gender, postoperative thyroglobulin (Tg) level and tumor size displayed statistically significant differences between the lung metastases and no distant metastasis groups. Fifty of the 102 patients with papillary thyroid carcinomas with lung metastases developed lung metastases during follow-up. Larger amounts of remnant thyroid tissues with higher Tg levels were noted in these patients compared to those without distant metastasis.
The prognosis of patients with papillary thyroid carcinoma with lung metastases at time of diagnosis is the same as for those whose lung metastases are discovered later. Survival analysis demonstrates no difference between lung metastases and multiorgan metastases. |
---|---|
AbstractList | Limited information is available on the presentation, treatment outcomes, and prognostic factors of papillary thyroid carcinoma with lung metastases.
This study retrospectively analyzed the data of 2003 patients with thyroid cancer who were treated and followed up at Chang Gung Memorial Hospital from January 1979 to December 2002. In total, 1516 papillary thyroid carcinomas were enrolled. One hundred two (6.7%) papillary thyroid carcinomas with lung metastases were followed including 57 women with mean age of 41.7 +/- 17.3 years and 45 men with mean age of 49.6 +/- 17.2 years. These patients included 52 patients with papillary thyroid carcinoma who presented with lung metastases at the time of diagnosis. The 102 cases of papillary thyroid carcinomas with lung metastases included 72 cases with lung metastases only, and 30 cases with other organ involvement.
After mean follow-up periods of 8.8 +/- 0.6 years, 28 (27.5%) of the patients with lung metastasis died, while 6 improved to clinical stage I. The 5-, 10-, 15-, and 20-year survival rates in patients with papillary thyroid carcinoma without distant metastasis and in the lung metastases groups were 99.0%, 98.5%, 98.0%, 98.0%, and 91.3%, 75.0%, 64.0%, 51.2%, respectively. Comparing the Kaplan-Meier survival curves between the patients with papillary thyroid carcinomas with lung metastases only and those with multiorgan metastases demonstrates no statistically significant difference in mortality rates. However, age, gender, postoperative thyroglobulin (Tg) level and tumor size displayed statistically significant differences between the lung metastases and no distant metastasis groups. Fifty of the 102 patients with papillary thyroid carcinomas with lung metastases developed lung metastases during follow-up. Larger amounts of remnant thyroid tissues with higher Tg levels were noted in these patients compared to those without distant metastasis.
The prognosis of patients with papillary thyroid carcinoma with lung metastases at time of diagnosis is the same as for those whose lung metastases are discovered later. Survival analysis demonstrates no difference between lung metastases and multiorgan metastases. |
Author | Lin, Jen-Der Hsueh, Chuen Chao, Tzu-Chieh Chou, Shuo-Chi |
Author_xml | – sequence: 1 givenname: Jen-Der surname: Lin fullname: Lin, Jen-Der email: einjd@adm.cgmh.org.tw organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Kweishan County, Taoyuan Hsien, Taiwan, Republic of China. einjd@adm.cgmh.org.tw – sequence: 2 givenname: Tzu-Chieh surname: Chao fullname: Chao, Tzu-Chieh – sequence: 3 givenname: Shuo-Chi surname: Chou fullname: Chou, Shuo-Chi – sequence: 4 givenname: Chuen surname: Hsueh fullname: Hsueh, Chuen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15650364$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jktLAzEURrOo2Jd7V5I_MOO9ec9Sii8o6MKuSybJ2Mi8mEyR_nsDKhz4Nh-HsyaLfugDIbcIJYKp7ufTpWQAosQMVLggKwQJhWZSLck6pS8AVEbza7JEqSRwJVYE3-0Y29ZOF5oF0xA9dXZysR86m-h3nE-0PfeftAuzTZmQtuSqsW0KN3-7IYenx4_dS7F_e37dPewLx7maC9QopHEmuCpoo5jMbaxxQdSeGRCsQqVrbbnX-dTwWionDErBGqN9MJxtyN2vdzzXXfDHcYpdzjz-t7MfuQBFhw |
CitedBy_id | crossref_primary_10_1089_thy_2009_0110 crossref_primary_10_1210_jc_2005_2838 crossref_primary_10_1089_thy_2016_0064 crossref_primary_10_1089_cbr_2008_0501 crossref_primary_10_5090_kjtcs_2010_43_1_113 crossref_primary_10_1007_s40477_023_00831_2 crossref_primary_10_1016_j_remnie_2012_10_003 crossref_primary_10_1177_1073274820914661 crossref_primary_10_1186_1756_6614_4_12 crossref_primary_10_11106_jkta_2012_5_2_157 crossref_primary_10_1089_thy_2015_0020 crossref_primary_10_1177_2042018813512361 crossref_primary_10_1245_s10434_011_1763_7 crossref_primary_10_1634_theoncologist_2009_0190 crossref_primary_10_1007_s12020_022_03045_4 crossref_primary_10_12998_wjcc_v9_i1_71 crossref_primary_10_1016_j_rmcr_2021_101574 crossref_primary_10_3109_00016489_2015_1116045 crossref_primary_10_3389_fendo_2022_791826 crossref_primary_10_1002_dc_23657 crossref_primary_10_1586_17446651_2013_863707 crossref_primary_10_11106_ijt_2016_9_2_59 crossref_primary_10_1016_j_remn_2012_04_007 crossref_primary_10_1002_dc_24969 crossref_primary_10_1097_MD_0000000000001063 crossref_primary_10_1007_s13139_013_0234_4 crossref_primary_10_1007_s12094_017_1792_1 crossref_primary_10_1177_15330338231167807 crossref_primary_10_1055_s_0042_1746175 crossref_primary_10_3389_fonc_2022_954759 crossref_primary_10_1089_thy_2006_16_ft_1 crossref_primary_10_11106_ijt_2024_17_1_1 crossref_primary_10_3892_ol_2015_4034 crossref_primary_10_1089_thy_2006_16_303 crossref_primary_10_1002_hed_24655 crossref_primary_10_1097_MD_0000000000006809 crossref_primary_10_1007_s00268_017_4206_1 crossref_primary_10_1002_dc_22850 crossref_primary_10_1245_s10434_019_07314_x crossref_primary_10_1002_jso_23967 crossref_primary_10_1089_thy_2006_16_109 crossref_primary_10_3919_jjsa_70_1660 crossref_primary_10_1097_01_cco_0000198975_36368_d3 crossref_primary_10_1111_ans_16652 crossref_primary_10_3892_ol_2014_2742 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/thy.2004.14.1091 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 15650364 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 1-M 123 29Q 34G 39C 4.4 53G 5RE AAQQT ABBKN ABJNI ABOCM ACGFO ACGFS ADBBV AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BNQNF CAG CGR COF CS3 CUY CVF DU5 EBS ECM EIF EJD EMOBN F5P IAO IER IHR IM4 INH INR ITC MV1 NPM NQHIM O9- P2P RIG RML RMSOB UDS UE5 |
ID | FETCH-LOGICAL-c336t-171458c8ec9e786252002fce4bd280429167b7a3d78c8f3b56c481542f87de832 |
ISSN | 1050-7256 |
IngestDate | Sat Sep 28 07:49:17 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c336t-171458c8ec9e786252002fce4bd280429167b7a3d78c8f3b56c481542f87de832 |
PMID | 15650364 |
ParticipantIDs | pubmed_primary_15650364 |
PublicationCentury | 2000 |
PublicationDate | 2004-Dec |
PublicationDateYYYYMMDD | 2004-12-01 |
PublicationDate_xml | – month: 12 year: 2004 text: 2004-Dec |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Thyroid (New York, N.Y.) |
PublicationTitleAlternate | Thyroid |
PublicationYear | 2004 |
SSID | ssj0016873 |
Score | 2.0171113 |
Snippet | Limited information is available on the presentation, treatment outcomes, and prognostic factors of papillary thyroid carcinoma with lung metastases.
This... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1091 |
SubjectTerms | Adult Aged Aging - physiology Carcinoma, Papillary - diagnostic imaging Carcinoma, Papillary - pathology Carcinoma, Papillary - secondary Female Follow-Up Studies Humans Iodine Radioisotopes Lung Neoplasms - diagnostic imaging Lung Neoplasms - secondary Male Middle Aged Radionuclide Imaging Retrospective Studies Risk Factors Sex Characteristics Survival Rate Thyroid Neoplasms - diagnostic imaging Thyroid Neoplasms - pathology |
Title | Papillary thyroid carcinomas with lung metastases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15650364 |
Volume | 14 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF58gHgR32_Jwetqu9lkk6NURcQWDxW8yb5CKpoWbQ_6653Z3TalVHxcQsgkIbvfl2F2dh6EnOaxNbwABIzRinLLcppL0aQsNTHnRnDp_B3tTnrzwG8fk8c6hcBllwzVmf6cm1fyH1ThGuCKWbJ_QHbyUrgA54AvHAFhOP4K43s5wKZBb2BBlh9v_Z7BQtO6V2HMj_ewvsC_jF2iJRiB7yFc8HlMEP_InHY8U-6Bu9Cty1b0sg7kbZXSuVi7nyPaKnu2rAX9kXOolqM-SiasAXT9Zk45CslnY1cDnwrb8NqxkTSoYL4S-ER98mmasClliDVH52rpRoZFTmFm3PoclPXZ7K0wz4NXhxqsLxPcK_1ZOlM3eyxaJIsiQ93XQT9O2F9KM-FTL8KAwgY2fNj57Ge5xk3-VTNLD2eCdNfJWlg7RBeeCBtkwVabZKUdoiO2SHPChyjwIar5ECEfIuRDVPNhmzxcX3VbNzS0xKA6jtMhxXb1SaYzq3MLo2JYNIsV2nJlWIa2RTMVSsjYCLipiFWSaqzGw1mRCWNBe--Qpapf2T0SJVIzC9Z9osBME7kGS1Eaq3KumIwbJtknu36wTwNf9-RpPA0H30oOyWrNmyOyXMCPZo_BahuqEwfAF2wWOlU |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Papillary+thyroid+carcinomas+with+lung+metastases&rft.jtitle=Thyroid+%28New+York%2C+N.Y.%29&rft.au=Lin%2C+Jen-Der&rft.au=Chao%2C+Tzu-Chieh&rft.au=Chou%2C+Shuo-Chi&rft.au=Hsueh%2C+Chuen&rft.date=2004-12-01&rft.issn=1050-7256&rft.volume=14&rft.issue=12&rft.spage=1091&rft_id=info:doi/10.1089%2Fthy.2004.14.1091&rft_id=info%3Apmid%2F15650364&rft_id=info%3Apmid%2F15650364&rft.externalDocID=15650364 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1050-7256&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1050-7256&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1050-7256&client=summon |